193 related articles for article (PubMed ID: 31090265)
1. Role of SIRT1 in hematologic malignancies.
Huang FT; Sun J; Zhang L; He X; Zhu YH; Dong HJ; Wang HY; Zhu L; Zou JY; Huang JW; Li L
J Zhejiang Univ Sci B; 2019 May; 20(5):391-398. PubMed ID: 31090265
[TBL] [Abstract][Full Text] [Related]
2. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.
Li L; Bhatia R
Curr Opin Hematol; 2015 Jul; 22(4):324-9. PubMed ID: 26049753
[TBL] [Abstract][Full Text] [Related]
3. Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis.
Yuan H; Wang Z; Li L; Zhang H; Modi H; Horne D; Bhatia R; Chen W
Blood; 2012 Feb; 119(8):1904-14. PubMed ID: 22207735
[TBL] [Abstract][Full Text] [Related]
4. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
5. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
[TBL] [Abstract][Full Text] [Related]
6. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
Wang Z; Chen CC; Chen W
Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells.
Wang Z; Yuan H; Roth M; Stark JM; Bhatia R; Chen WY
Oncogene; 2013 Jan; 32(5):589-98. PubMed ID: 22410779
[TBL] [Abstract][Full Text] [Related]
9. Roles of SIRT1 in leukemogenesis.
Chen W; Bhatia R
Curr Opin Hematol; 2013 Jul; 20(4):308-13. PubMed ID: 23519155
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia.
Sasca D; Hähnel PS; Szybinski J; Khawaja K; Kriege O; Pante SV; Bullinger L; Strand S; Strand D; Theobald M; Kindler T
Blood; 2014 Jul; 124(1):121-33. PubMed ID: 24855208
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
[TBL] [Abstract][Full Text] [Related]
12. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide increases the sensitivity of chronic myeloid leukemia cells to doxorubicin via the inhibition of SIRT1.
Pan S; Leng J; Deng X; Ruan H; Zhou L; Jamal M; Xiao R; Xiong J; Yin Q; Wu Y; Wang M; Yuan W; Shao L; Zhang Q
J Cell Biochem; 2020 Jan; 121(1):574-586. PubMed ID: 31407410
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells.
Roth M; Wang Z; Chen WY
Oncotarget; 2016 Aug; 7(31):50195-50214. PubMed ID: 27384990
[TBL] [Abstract][Full Text] [Related]
15. Role of SIRT1 in Chemoresistant Leukemia.
Fajardo-Orduña GR; Ledesma-Martínez E; Aguiñiga-Sanchez I; Weiss-Steider B; Santiago-Osorio E
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833921
[TBL] [Abstract][Full Text] [Related]
16. AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.
Zhou L; Wang Q; Chen X; Fu L; Zhang X; Wang L; Deng A; Li D; Liu J; Lv N; Wang L; Li Y; Liu D; Yu L; Dou L
Exp Hematol; 2017 Feb; 46():62-69. PubMed ID: 27725192
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
[TBL] [Abstract][Full Text] [Related]
18. Revert the SIRT: Normalizing SIRT1 Activity in Myelodysplastic Stem Cells.
Simeoni F; Somervaille TCP
Cell Stem Cell; 2018 Sep; 23(3):315-317. PubMed ID: 30193128
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
